World-class bioprocessing and manufacturing

Discover the facts about Oxford BioMedica's manufacturing facility

Oxford BioMedica is a world leader in the development of lentiviral vector-based products. Their investment in building bioprocessing capability in-house is enabling industry partners to advance valuable gene and cell therapy products to the market. This capabilties brochure positions Oxford BioMedica as the partner of choice for life sciences companies discovering and developing gene and cell therapy treatments. 

investor communication materials / marketing collateral / conference and exhibition materials